無料レポート プレゼントキャンペーン 実施中 : メールサービスに新規登録いただいた方にご用意した無料レポートをご提供

株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

POC (ポイントオブケア) 分析装置の世界市場:医療機器のパイプライン評価

Point-of-Care (POC) Analyzers - Medical Devices Pipeline Assessment, 2018

発行 GlobalData 商品コード 363398
出版日 ページ情報 英文 118 Pages
即納可能
価格
本日の銀行送金レート: 1USD=113.41円で換算しております。
Back to Top
POC (ポイントオブケア) 分析装置の世界市場:医療機器のパイプライン評価 Point-of-Care (POC) Analyzers - Medical Devices Pipeline Assessment, 2018
出版日: 2018年07月06日 ページ情報: 英文 118 Pages
概要

当レポートでは、世界のPOC (Point of Care:臨床現場向け) 分析装置の市場における、主要なパイプライン製品とその治験の進行状況について調査すると共に、製品の機能・特性の比較分析 (治験の進行段階別) や、主要企業のプロファイルおよび代表的製品、昨今の市場動静 (業績報告・資本取引動向など) といった情報を取りまとめてお届けいたします。

第1章 目次

第2章 イントロダクション

  • POC分析装置の概要

第3章 治験中の製品

  • パイプライン製品:治験段階別
  • パイプライン製品:地域別
  • パイプライン製品:規制経路別
  • パイプライン製品:推定認証時期別

第4章 治験中のパイプライン製品:企業別

  • POC分析装置の企業:治験段階別のパイプライン製品
  • POC分析装置:治験段階別のパイプライン製品

第5章 POC分析装置市場:企業・製品の概要

  • Akers Biosciences, Inc.
    • パイプライン製品および進行中の治験の概要
  • Akonni Biosystems, Inc.
  • ApoCell, Inc.
  • Attophotonics Biosciences GmbH
  • Bio-Alternative Medical Devices Ltd
  • BioDirection, Inc.
  • BioMedomics, Inc
  • bioMerieux S.A.
  • Biopico Systems Inc.
  • Boston University
  • Cepheid
  • Co-Diagnostics HBDC, Inc.
  • Indian Institute of Technology, Madras
  • John Hopkins University
  • Magna Diagnostics GmbH
  • McKesson Corporation
  • Nanomix, Inc.
  • OncoGenesis
  • Phoenix Biosystems Inc
  • PositiveID Corporation
  • Quanterix Corporation
  • Radisens Diagnostics Limited
  • Rapid Biosensor Systems
  • SenGenix, Inc.
  • Thermal Gradient, Inc.
  • University of Alberta
  • University of California, Berkeley
  • University of California, Davis
  • Wellstat Diagnostics, LLC
  • Xen Biofluidx Inc

第6章 POC分析装置市場:昨今の動向 (全3件)

第7章 付録

図表一覧

図表

1.1 List of Tables

  • Table 1: Point-of-Care (POC) Analyzers - Pipeline Products by Stage of Development 11
  • Table 2: Point-of-Care (POC) Analyzers - Pipeline Products by Territory 12
  • Table 3: Point-of-Care (POC) Analyzers - Pipeline Products by Regulatory Path 13
  • Table 4: Point-of-Care (POC) Analyzers - Pipeline Products by Estimated Approval Date 14
  • Table 5: Point-of-Care (POC) Analyzers - Ongoing Clinical Trials 15
  • Table 6: Point-of-Care (POC) Analyzers Companies - Pipeline Products by Stage of Development 16
  • Table 7: Point-of-Care (POC) Analyzers - Pipeline Products by Stage of Development 19
  • Table 8: Acrongenomics Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 21
  • Table 9: BioLED Device - Diabetes Management - Product Status 21
  • Table 10: BioLED Device - Diabetes Management - Product Description 21
  • Table 11: AgPlus Diagnostics LTD Pipeline Products & Ongoing Clinical Trials Overview 22
  • Table 12: AgPlus Diagnostic System - Product Status 22
  • Table 13: AgPlus Diagnostic System - Product Description 22
  • Table 14: Akers Biosciences Inc Pipeline Products & Ongoing Clinical Trials Overview 23
  • Table 15: minDNAnalyzer - Product Status 23
  • Table 16: minDNAnalyzer - Product Description 23
  • Table 17: Akonni Biosystems Inc Pipeline Products & Ongoing Clinical Trials Overview 24
  • Table 18: TruDx 2000 Platform - Product Status 24
  • Table 19: TruDx 2000 Platform - Product Description 24
  • Table 20: Alere Inc Pipeline Products & Ongoing Clinical Trials Overview 25
  • Table 21: Clondiag HIV Molecular Device - Product Status 25
  • Table 22: Clondiag HIV Molecular Device - Product Description 25
  • Table 23: Analytical Diagnostic Solutions Inc Pipeline Products & Ongoing Clinical Trials Overview 26
  • Table 24: POC Device - Malaria - Product Status 26
  • Table 25: POC Device - Malaria - Product Description 26
  • Table 26: ApoCell Inc Pipeline Products & Ongoing Clinical Trials Overview 27
  • Table 27: ApoStream System - Product Status 27
  • Table 28: ApoStream System - Product Description 27
  • Table 29: Ativa Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 28
  • Table 30: Ativa Micro-Lab System - Product Status 28
  • Table 31: Ativa Micro-Lab System - Product Description 28
  • Table 32: Atonomics A/S Pipeline Products & Ongoing Clinical Trials Overview 29
  • Table 33: Atolyzer PoC - Product Status 29
  • Table 34: Atolyzer PoC - Product Description 29
  • Table 35: Binghamton University Pipeline Products & Ongoing Clinical Trials Overview 30
  • Table 36: U-PAC - Product Status 30
  • Table 37: U-PAC - Product Description 30
  • Table 38: Bio-Alternative Medical Devices Ltd Pipeline Products & Ongoing Clinical Trials Overview 31
  • Table 39: Magnetic Immunoassay Detection System - Product Status 31
  • Table 40: Magnetic Immunoassay Detection System - Product Description 31
  • Table 41: BioMedomics Inc Pipeline Products & Ongoing Clinical Trials Overview 32
  • Table 42: TR-LFIA Diagnostic Platform - Product Status 32
  • Table 43: TR-LFIA Diagnostic Platform - Product Description 32
  • Table 44: bioMerieux SA Pipeline Products & Ongoing Clinical Trials Overview 33
  • Table 45: Magnotech System - Product Status 33
  • Table 46: Magnotech System - Product Description 33
  • Table 47: Biopico Systems Inc Pipeline Products & Ongoing Clinical Trials Overview 34
  • Table 48: MONITOR System - Product Status 34
  • Table 49: MONITOR System - Product Description 34
  • Table 50: Boston University Pipeline Products & Ongoing Clinical Trials Overview 35
  • Table 51: Point-Of-Care Device - Allergen-Specific IgE - Product Status 35
  • Table 52: Point-Of-Care Device - Allergen-Specific IgE - Product Description 35
  • Table 53: Canon USA Inc Pipeline Products & Ongoing Clinical Trials Overview 36
  • Table 54: Automated Diagnostic System - Infectious Disease - Product Status 36
  • Table 55: Automated Diagnostic System - Infectious Disease - Product Description 36
  • Table 56: CardioGenics Inc Pipeline Products & Ongoing Clinical Trials Overview 37
  • Table 57: QL Care Analyzer - Product Status 37
  • Table 58: QL Care Analyzer - Product Description 37
  • Table 59: Cepheid Pipeline Products & Ongoing Clinical Trials Overview 38
  • Table 60: GeneXpert Omni - Product Status 38
  • Table 61: GeneXpert Omni - Product Description 38
  • Table 62: Cepheid - Ongoing Clinical Trials Overview 39
  • Table 63: GeneXpert Omni - Xpert Omni Performance Evaluation for Linkage to Tuberculosis Care: The XPEL TB Trial 40
  • Table 64: ChipCare Corp Pipeline Products & Ongoing Clinical Trials Overview 41
  • Table 65: Polyvalent Analyzer (PAx) - Product Status 41
  • Table 66: Polyvalent Analyzer (PAx) - Product Description 41
  • Table 67: City, University of London Pipeline Products & Ongoing Clinical Trials Overview 42
  • Table 68: POC Device - Mood Disorders - Product Status 42
  • Table 69: POC Device - Mood Disorders - Product Description 42
  • Table 70: Co-Diagnostics HBDC, Inc. Pipeline Products & Ongoing Clinical Trials Overview 43
  • Table 71: LightPCR - Product Status 43
  • Table 72: LightPCR - Product Description 43
  • Table 73: Diagnostics For All Inc Pipeline Products & Ongoing Clinical Trials Overview 44
  • Table 74: Paper-Based Diagnostic Device - Hypertensive Disorders - Product Status 44
  • Table 75: Paper-Based Diagnostic Device - Hypertensive Disorders - Product Description 44
  • Table 76: ExcitePCR Corp Pipeline Products & Ongoing Clinical Trials Overview 45
  • Table 77: FireflyDX-Handheld - Product Status 45
  • Table 78: FireflyDX-Handheld - Product Description 45
  • Table 79: Exosome Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview 46
  • Table 80: Shahky - Product Status 46
  • Table 81: Shahky - Product Description 46
  • Table 82: First Light Biosciences Inc Pipeline Products & Ongoing Clinical Trials Overview 47
  • Table 83: MultiPath Analyzer - Product Status 47
  • Table 84: MultiPath Analyzer - Product Description 47
  • Table 85: Florida International University Pipeline Products & Ongoing Clinical Trials Overview 48
  • Table 86: Cortisol Detector - Product Status 48
  • Table 87: Cortisol Detector - Product Description 48
  • Table 88: Fluxergy LLC Pipeline Products & Ongoing Clinical Trials Overview 49
  • Table 89: Fluxergy Analyzer Beta - Product Status 49
  • Table 90: Fluxergy Analyzer Beta - Product Description 49
  • Table 91: Giner Inc Pipeline Products & Ongoing Clinical Trials Overview 50
  • Table 92: Home Monitoring System - Blood Lithium - Product Status 50
  • Table 93: Home Monitoring System - Blood Lithium - Product Description 50
  • Table 94: Indian Institute of Technology Chennai Pipeline Products & Ongoing Clinical Trials Overview 51
  • Table 95: Microfluidic Flow Analyzer - Product Status 51
  • Table 96: Microfluidic Flow Analyzer - Product Description 51
  • Table 97: Maxygen-mobile DNA tests Pipeline Products & Ongoing Clinical Trials Overview 52
  • Table 98: Maxygen POC Device - Product Status 52
  • Table 99: Maxygen POC Device - Product Description 52
  • Table 100: mBio Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview 53
  • Table 101: MBio Array System - Product Status 53
  • Table 102: MBio Array System - Product Description 53
  • Table 103: MBio CD4 System - Product Status 54
  • Table 104: MBio CD4 System - Product Description 54
  • Table 105: McKesson Corp Pipeline Products & Ongoing Clinical Trials Overview 55
  • Table 106: Proventys PDx System - Product Status 55
  • Table 107: Proventys PDx System - Product Description 55
  • Table 108: MML Ltd Pipeline Products & Ongoing Clinical Trials Overview 56
  • Table 109: MIDS Cardiac - Product Status 56

1.2 List of Figures

  • Figure 1: Point-of-Care (POC) Analyzers - Pipeline Products by Stage of Development 11
  • Figure 2: Point-of-Care (POC) Analyzers - Pipeline Products by Territory 12
  • Figure 3: Point-of-Care (POC) Analyzers - Pipeline Products by Regulatory Path 13
  • Figure 4: Point-of-Care (POC) Analyzers - Pipeline Products by Estimated Approval Date 14
  • Figure 5: Point-of-Care (POC) Analyzers - Ongoing Clinical Trials 15
目次
Product Code: GDME0660EPD

GlobalData's Medical Devices sector report, "Point-of-Care (POC) Analyzers - Medical Devices Pipeline Assessment, 2018" provides an overview of Point-of-Care (POC) Analyzers currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Point-of-Care (POC) Analyzers pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Point-of-Care (POC) Analyzers under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Point-of-Care (POC) Analyzers and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry.

Reasons to buy

The report enables you to -

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Point-of-Care (POC) Analyzers under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product's current stage of development, territory and estimated launch date.

1 Table of Contents

1 Table of Contents 2

  • 1.1 List of Tables 5
  • 1.2 List of Figures 8

2 Introduction 9

  • 2.1 Point-of-Care (POC) Analyzers Overview 9

3 Products under Development 10

  • 3.1 Point-of-Care (POC) Analyzers - Pipeline Products by Stage of Development 10
  • 3.2 Point-of-Care (POC) Analyzers - Pipeline Products by Territory 11
  • 3.3 Point-of-Care (POC) Analyzers - Pipeline Products by Regulatory Path 12
  • 3.4 Point-of-Care (POC) Analyzers - Pipeline Products by Estimated Approval Date 13
  • 3.5 Point-of-Care (POC) Analyzers - Ongoing Clinical Trials 14

4 Point-of-Care (POC) Analyzers - Pipeline Products under Development by Companies 15

  • 4.1 Point-of-Care (POC) Analyzers Companies - Pipeline Products by Stage of Development 15
  • 4.2 Point-of-Care (POC) Analyzers - Pipeline Products by Stage of Development 18

5 Point-of-Care (POC) Analyzers Companies and Product Overview 20

  • 5.1 Acrongenomics Inc. (Inactive) Company Overview 20
  • 5.2 AgPlus Diagnostics LTD Company Overview 21
  • 5.3 Akers Biosciences Inc Company Overview 22
  • 5.4 Akonni Biosystems Inc Company Overview 23
  • 5.5 Alere Inc Company Overview 24
  • 5.6 Analytical Diagnostic Solutions Inc Company Overview 25
  • 5.7 ApoCell Inc Company Overview 26
  • 5.8 Ativa Medical Inc Company Overview 27
  • 5.9 Atonomics A/S Company Overview 28
  • 5.10 Binghamton University Company Overview 29
  • 5.11 Bio-Alternative Medical Devices Ltd Company Overview 30
  • 5.12 BioMedomics Inc Company Overview 31
  • 5.13 bioMerieux SA Company Overview 32
  • 5.14 Biopico Systems Inc Company Overview 33
  • 5.15 Boston University Company Overview 34
  • 5.16 Canon USA Inc Company Overview 35
  • 5.17 CardioGenics Inc Company Overview 36
  • 5.18 Cepheid Company Overview 37
  • 5.19 ChipCare Corp Company Overview 40
  • 5.20 City, University of London Company Overview 41
  • 5.21 Co-Diagnostics HBDC, Inc. Company Overview 42
  • 5.22 Diagnostics For All Inc Company Overview 43
  • 5.23 ExcitePCR Corp Company Overview 44
  • 5.24 Exosome Diagnostics Inc Company Overview 45
  • 5.25 First Light Biosciences Inc Company Overview 46
  • 5.26 Florida International University Company Overview 47
  • 5.27 Fluxergy LLC Company Overview 48
  • 5.28 Giner Inc Company Overview 49
  • 5.29 Indian Institute of Technology Chennai Company Overview 50
  • 5.30 Maxygen-mobile DNA tests Company Overview 51
  • 5.31 mBio Diagnostics Inc Company Overview 52
  • 5.32 McKesson Corp Company Overview 54
  • 5.33 MML Ltd Company Overview 55
  • 5.34 Molecular Warehouse Ltd Company Overview 56
  • 5.35 Nalia Systems Ltd Company Overview 57
  • 5.36 Newcastle University Company Overview 58
  • 5.37 Nikkiso Co Ltd Company Overview 60
  • 5.38 Ohmx Corp Company Overview 61
  • 5.39 OncoGenesis Company Overview 62
  • 5.40 Pacific Nanoscience, Inc. Company Overview 63
  • 5.41 Parallax Health Sciences Inc Company Overview 64
  • 5.42 POC Medical Systems Inc. Company Overview 65
  • 5.43 Quanterix Corp Company Overview 66
  • 5.44 Qvella Corporation Company Overview 67
  • 5.45 Radisens Diagnostics Ltd Company Overview 68
  • 5.46 SenGenix Inc Company Overview 69
  • 5.47 SFC Fluidics LLC Company Overview 70
  • 5.48 StemTek Therapeutics SL Company Overview 71
  • 5.49 Thermal Gradient Inc Company Overview 72
  • 5.50 Trinity Biotech Plc Company Overview 74
  • 5.51 Two Pore Guys Inc Company Overview 75
  • 5.52 University of Calgary Company Overview 76
  • 5.53 University of California Berkeley Company Overview 77
  • 5.54 Wellstat Diagnostics LLC Company Overview 80

6 Point-of-Care (POC) Analyzers- Recent Developments 81

  • 6.1 Jun 28, 2018: McKesson Reaffirms Fiscal 2019 Guidance and Provides Preliminary Guidance for the First Quarter 81
  • 6.2 Jun 25, 2018: PositiveID Subsidiary Chief Science Officer Joins Cambridge Healthtech Institute's 26th Biodetection Technologies: Biothreat and Pathogen Detection 81
  • 6.3 Jun 21, 2018: Abbott Receives FDA Clearance for Afinion HbA1c Dx for Diagnosing Diabetes 81
  • 6.4 Jun 20, 2018: PositiveID CEO Details New Distribution Agreement with Leading Non-Invasive Patient Monitoring Technology Company 82

7 Appendix 114

  • 7.1 Methodology 114
  • 7.2 About GlobalData 117
  • 7.3 Contact Us 117
  • 7.4 Disclaimer 117
Back to Top